NSCLC patient postoperative short-period recurrence metastasis risk evaluating system

Abstract

The invention provides an NSCLC patient postoperative short-period recurrence metastasis risk evaluating system which comprises a preprocessing module, a characteristic extracting module, an AI network cluster risk evaluating module and an ANFIS network integrated risk evaluating module. The preprocessing module is used for collecting and preprocessing multidimensional patient clinical data. The multidimensional patient clinical data comprise patient preoperative CT radiomics data, tumor histopathology data and tumor clinical. The characteristic extracting module is used for extracting the characteristic of the data sample after preprocessing. The AI network cluster risk evaluating module is used for performing recurrence risk probability evaluation on the extracted sample characteristic.The ANFIS network integrated risk evaluating module is used for using a recurrence risk probability evaluation result as an input characteristic vector, establishes an ANFIS network, uses a recurrence / metastasis risk quantification probability and dangerous degree as the output, and performs final integrated risk evaluation. The system can supply a reference for selecting a radial curing postoperative comprehensive treatment plan by a lung cancer patient and has high predicting accuracy.

Description

technical field [0001] The present invention relates to the field of artificial intelligence technology and smart medical technology, in particular to a short-term postoperative recurrence / transfer risk assessment system for NSCLC patients. Background technique [0002] Lung cancer is one of the most common malignant tumors in the world, and it has become the first cause of death from malignant tumors in urban population in my country. Non-small cell lung cancer (NSCLC) includes squamous cell carcinoma (squamous cell carcinoma), adenocarcinoma, and large cell carcinoma. The proportion of NSCLC patients accounts for about 80% of all lung cancer patients, and about 75% of patients are in the middle and advanced stages when they are discovered. At the same time, non-small cell lung cancer has the characteristics of high malignancy, easy recurrence and metastasis, and low five-year survival rate. Developing individualized treatment plans for NSCLC patients and timely comprehens...

AI Technical Summary

Problems solved by technology

Because radiotherapy and chemotherapy have great side effects on the patient's body, clinical trials have shown that radiotherapy and chemotherapy for patients with low risk of recurrence / metastasis after radical surgery will not only fail to benefit the patient, but will cause a decrease in their quality of life and disease resistance and many other damages, leading to a reduction in the five-year survival rate

Images